Oxford Partial Knee System
Biomet Manufacturing Corp · Decision date Oct 26, 2026
What did the FDA decide?
The FDA recorded decision OK30 on 2026-10-26 for supplement P010014/S120, titled Oxford Partial Knee System, submitted by Biomet Manufacturing Corp. The supplement is a 30-Day Notice with the recorded reason Process Change - Manufacturer/Sterilizer/Packager/Supplier. The device category is a unicompartmental, semi-constrained, metal/polymer, mobile-bearing femorotibial knee prosthesis under product code NRA, in the orthopedic specialty.
The recorded statement covers a change to the in-process inspection frequency for the tibial components of the Oxford Partial Knee System at the ZOML Shannon, Ireland manufacturing facility. This is a supplement to the existing application, not a new approval of the whole knee system. The source lists no supporting documents, so the inspection-frequency specifics and any FDA review detail beyond the recorded fields are unknown.
Whether the changed inspection frequency affects component conformance or clinical performance cannot be determined from the available record; that question remains open.
FDA approval order statement
change the in-process inspection frequency for the tibial components of the Oxford Partial Knee System at the ZOML Shannon, Ireland manufacturing facility
- Regulatory pathway
- PMA supplement
- Supplement type
- 30-Day Notice
- Clinical specialty
- Orthopedic
- Decision date
- Oct 26, 2026
- FDA change category
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- P010014/S120
- Regulatory pathway
- PMA supplement
- Applicant
- Biomet Manufacturing Corp
- Product code
- NRA
- Decision code
- OK30
- Decision date
- Oct 26, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Prosthesis, knee, femorotibial, unicompartmental, semi-constrained, metal/polymer, mobile bearing.
- Applicant
- Biomet Manufacturing Corp
- Product code
- NRA
- FDA device class
- 3
For the original device and its historical approval scope, see PMA P010014. Subsequent supplements may change the device or its indications.
FDA decision timeline
P010014 · Original PMA
OXFORD(TM) MENISCAL UNICOMPARTMENTAL KNEE SYSTEM
P010014/S118 · Related supplement
Oxford Partial Knee Anatomic Vivacit-E Meniscal Bearings
P010014/S120 received
Application receipt date recorded by FDA.
P010014/S119 · Related supplement
Cementless Oxford Partial Knee System
P010014/S120 · FDA decision
30-Day Notice
Timeline entries are records held by MedtechLedger for P010014. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P010014
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Biomet Manufacturing Corp | PMA approval | Apr 21, 2004 | FDA | |
| Biomet Manufacturing Corp | PMA supplement | Sep 1, 2026 | FDA | |
Cementless Oxford Partial Knee SystemP010014/S119 | Biomet Manufacturing Corp | PMA supplement | Oct 6, 2026 | FDA |
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Biomet Manufacturing Corp
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- 56 E. Bell Dr.,, P.O. Box 587, Warsaw, IN, 46581
Sources and methodology
- Original FDA record: P010014/S120
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records

